Hemas Holdings PLC (HHL) - 4Q FY25
Earnings Reviews
04/06/2025
228
0
HHL reported an EPS of LKR 0.90 for 4Q FY25, along with the PATMI growth of 63.6% YoY to LKR 2.6bn. Group topline witnessed a marginal drop of 3.5% YoY to LKR 30.3bn owing to the decline stemming from Consumer Brands. EBIT margins, however, strengthened to 10.5% (from previous 9.5%) supported by operational efficiencies and favourable macro conditions. We believe HHL’s strong positioning in the Healthcare and Consumer Brands verticals will continue to drive earnings growth.
You must login to post a comment.